{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T23:16:11Z","timestamp":1751411771667,"version":"3.40.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ijid.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:10:28Z","timestamp":1697526628000},"page":"75-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study"],"prefix":"10.1016","volume":"137","author":[{"given":"Erlend","family":"Ravlo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Ianevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirin","family":"Starheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Lysvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Smura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaily","family":"Kivi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia-Liisa","family":"Voolaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kati","family":"Plaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart","family":"Ustav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Mart","family":"Ustav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Zusinaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanel","family":"Tenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-9693","authenticated-orcid":false,"given":"Reet","family":"Kurg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-3791","authenticated-orcid":false,"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti","family":"Walstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-4355","authenticated-orcid":false,"given":"Svein Arne","family":"Nordb\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3983-6545","authenticated-orcid":false,"given":"Mari","family":"Kaarb\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-4945","authenticated-orcid":false,"given":"Karin","family":"Ernits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-6955","authenticated-orcid":false,"given":"Denis E.","family":"Kainov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9102-8409","authenticated-orcid":false,"given":"Mona H\u00f8ys\u00e6ter","family":"Fenstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.10.011_bib0001","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/emph\/eoac010","article-title":"Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution","volume":"10","author":"Amicone","year":"2022","journal-title":"Evol Med Public Health"},{"key":"10.1016\/j.ijid.2023.10.011_bib0002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coviro.2021.08.010","article-title":"Structure of SARS-CoV-2 spike protein","volume":"50","author":"Zhang","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ijid.2023.10.011_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.610300","article-title":"Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases","volume":"11","author":"Carsetti","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2023.10.011_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/v12060642","article-title":"Potential antiviral options against SARS-CoV-2 infection","volume":"12","author":"Ianevski","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2023.10.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104402","article-title":"SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination","volume":"87","author":"Liew","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.ijid.2023.10.011_bib0006","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.35.2100793","article-title":"Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021","volume":"26","author":"Sepp\u00e4l\u00e4","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2023.10.011_bib0007","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/infdis\/jiad040","article-title":"Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance","volume":"227","author":"Bozio","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2023.10.011_bib0008","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijid.2023.10.011_bib0009","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijid.2021.12.321","article-title":"No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway","volume":"115","author":"Veneti","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.10.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011532","article-title":"Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on spike and provides antiviral protection through inhalation-based delivery in non-human primates","volume":"19","author":"Hermet","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2023.10.011_bib0011","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/v12101178","article-title":"Identification and tracking of antiviral drug combinations","volume":"12","author":"Ianevski","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2023.10.011_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105596","article-title":"Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models","volume":"25","author":"Takeshita","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ijid.2023.10.011_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100189","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Reports Medicine"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223007488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223007488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T20:09:16Z","timestamp":1717013356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223007488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":13,"alternative-id":["S1201971223007488"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.10.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}